SK76696A3 - Pentoxifyllin allone or in combination with corticosteroid - Google Patents

Pentoxifyllin allone or in combination with corticosteroid Download PDF

Info

Publication number
SK76696A3
SK76696A3 SK766-96A SK76696A SK76696A3 SK 76696 A3 SK76696 A3 SK 76696A3 SK 76696 A SK76696 A SK 76696A SK 76696 A3 SK76696 A3 SK 76696A3
Authority
SK
Slovakia
Prior art keywords
day
patient
attacks
combination
ptx
Prior art date
Application number
SK766-96A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Rieckmann
Original Assignee
Rentschler Arzneimittel Gmbh A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rentschler Arzneimittel Gmbh A filed Critical Rentschler Arzneimittel Gmbh A
Publication of SK76696A3 publication Critical patent/SK76696A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK766-96A 1993-12-16 1994-12-16 Pentoxifyllin allone or in combination with corticosteroid SK76696A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4343034A DE4343034C1 (de) 1993-12-16 1993-12-16 Verwendung von Pentoxifyllin zur Behandlung von Multipler Sklerose
PCT/EP1994/004188 WO1995016450A1 (de) 1993-12-16 1994-12-16 Verwendung von pentoxifyllin zur behandlung von multipler sklerose

Publications (1)

Publication Number Publication Date
SK76696A3 true SK76696A3 (en) 1997-04-09

Family

ID=6505251

Family Applications (1)

Application Number Title Priority Date Filing Date
SK766-96A SK76696A3 (en) 1993-12-16 1994-12-16 Pentoxifyllin allone or in combination with corticosteroid

Country Status (10)

Country Link
EP (1) EP0734262A1 (fi)
JP (1) JPH09506603A (fi)
CA (1) CA2176848A1 (fi)
CZ (1) CZ170896A3 (fi)
DE (1) DE4343034C1 (fi)
FI (1) FI962473A (fi)
NO (1) NO962503L (fi)
PL (1) PL314588A1 (fi)
SK (1) SK76696A3 (fi)
WO (1) WO1995016450A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19544768C1 (de) * 1995-11-30 1997-07-10 Rentschler Arzneimittel Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
WO2001087280A2 (de) * 2000-05-15 2001-11-22 Bayer Aktiengesellschaft Mittel zur schubtherapie von autoimmunerkrankungen
WO2007041506A1 (en) * 2005-10-03 2007-04-12 Melior Discovery, Inc. Purine formulations and methods for managing disorders
AU2013329421A1 (en) * 2012-10-09 2015-04-30 Biogen Ma Inc. Combination therapies and uses for treatment of demyelinating disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307883A1 (en) * 1992-03-12 1993-09-23 Westarp Martin Egon Dr Med Use of anti-retroviral substances - to treat motor-neuronal diseases
US5763446A (en) * 1992-03-26 1998-06-09 University Of Southern California Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases

Also Published As

Publication number Publication date
NO962503D0 (no) 1996-06-13
PL314588A1 (en) 1996-09-16
CZ170896A3 (en) 1997-01-15
FI962473A0 (fi) 1996-06-14
JPH09506603A (ja) 1997-06-30
WO1995016450A1 (de) 1995-06-22
DE4343034C1 (de) 1995-06-08
FI962473A (fi) 1996-07-16
EP0734262A1 (de) 1996-10-02
NO962503L (no) 1996-06-13
CA2176848A1 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
Painter et al. Phenobarbital and diphenylhydantoin levels inneonates with seizures
Wakefield et al. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease
US4978680A (en) Method for the prevention and control of epileptic seizure
HU206042B (en) Process for producing pharmaceutical compositions comprising indole-3-carboxylic acid-endo-8-methyl-8-azabicyclo/3.2.1./oct-3-yl ester and/or 1,2,3-9-tetrahydro-9-methyl-3-(2-methyl-1h-imidazol-1-yl)-methyl-4h-carbazol-4-one, with an activity preventing or reducing opiate-, alcohol- and nicotine-dependence
JPH0637395B2 (ja) ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤
SK76696A3 (en) Pentoxifyllin allone or in combination with corticosteroid
US3852453A (en) Method of enhancing vincamine compositions
Barry The use of high-dose pulse methylprednisolone in rheumatoid arthritis: unproved therapy
US9433608B2 (en) Compositions and method for treatment of ischemic neuronal reperfusion injury
CA2191230C (en) 2-halo-2'-deoxyadenosine treatment for inflammatory bowel disease
US2993835A (en) Anticonvulsant succinimide
US3808330A (en) Method for treatment of hypertensive disease
EP0347927A2 (de) Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on (Ebselen) zur Herstellung von Arzneimitteln zur Behandlung von Malaria
WO2018220457A1 (en) Vitamin b1 in high doses for use in the medical treatment of motor symptoms of some sporadic neurodegenerative diseases, of genetic origin, and of cluster headache and of migraine headache
EP0256629A2 (en) Tolrestat or a salt thereof as an immuno-stimulating agent
US6159965A (en) Anti-emetic pharmaceutical compositions containing methotrimeprazine
WO2010020789A2 (en) Medicament and treatment for infections
Joss et al. BRL 43694: a novel antiemetic to prevent nausea and vomiting induced by chemotherapy
KR960014873B1 (ko) 제피론을 함유하는 공황(恐慌)장애 경감용 약학 조성물
US2991225A (en) Omicron-methylbenzhydryl-beta-dimethylaminoethyl ether process and composition for symptomatic relief of the syndrome of parkinsonism and of spastic skeletal muscle disorders
JPS6116A (ja) 有機化合物に関する改良
Masugi et al. Combination of ascorbic acid and methylprednisolone pulse therapy in the treatment of idiopathic thrombocytopenic purpura
Ujefa et al. PHENYTOIN TOXICITY AND IT’S MANAGEMENT-A SYSTEMATIC
Bowcock et al. Pyrimethamine in the myeloproliferative disorders: a forgotten treatment?
EP0245954A2 (en) Use of etodolac for lowering uric acid blood levels